Sort
11,323 grants matching “glioblastoma”
Quantitative MR-PET for Therapy Assessment in Glioma Patients
$611,865Ciprian Catana · Massachusetts General Hospital · R01 · FY2012 · CA
Project 1: Design Rules for Spherical Nucleic Acids that Target Cancer
$611,563Milan Mrksich · Northwestern University At Chicago · U54 · FY2016 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$611,308Lance L Munn · Massachusetts General Hospital · U01 · FY2022 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$611,307Lance L Munn · Massachusetts General Hospital · U01 · FY2023 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$610,603Brad Kahl · University Of Wisconsin-Madison · U10 · FY2008 · CA
Enhanced Deuterium Metabolic Imaging (DMI) of Metabolic Reprogramming in Brain Tumors
$610,360Daniel M Spielman · Stanford University · R01 · FY2023 · CA
Multi-receptor Targeting of Glioblastoma
$610,326Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2022 · CA
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.
$610,097Yvonne Yu-Hsuan Chen · University Of California Los Angeles · R01 · FY2025 · NS
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies
$610,088Yuanpei Li · University Of California At Davis · R01 · FY2022 · EB
Enhanced Delivery of Cytotoxic Neural Stem Cells for Treatment of Glioblastoma Multiforme Using an Innovative In-situ Thermogelling Hydrogel and Focused Ultrasound
$609,749Soumya Rahima Benhabbour · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Regulating the glioma immune microenvironment
$609,700Joanna Phillips · University Of California, San Francisco · R01 · FY2025 · NS
Hyperpolarized 13C MRSI Monitoring of Pyruvate Metabolism to Assess Drug Action
$609,543Russell O Pieper · University Of California, San Francisco · P01 · FY2017 · CA
Magnetofluorescent nanoplatform for glioblastoma therapy
$608,922John S Yu · Cedars-Sinai Medical Center · R01 · FY2022 · CA
In vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
$608,784Xiaonan Li · Lurie Children'S Hospital Of Chicago · U01 · FY2022 · CA
Brain Tumor-Penetrating Nanoparticle Delivery with MR-Guided Focused Ultrasound
$608,149Richard J Price · University Of Virginia · R01 · FY2015 · CA
Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
$607,842Benjamin M. Ellingson · University Of California Los Angeles · R01 · FY2025 · CA
Magnetofluorescent nanoplatform for glioblastoma therapy
$607,833John S Yu · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Generating Synthetic Lethality in Glioblastoma with a First-In-Class Non-Muscle Myosin II Inhibitor
$607,634Steven S Rosenfeld · Mayo Clinic Jacksonville · R01 · FY2025 · CA
Identifying and exploiting molecular abnormalities of tumor vasculature
$607,580Michael Clark Oldham · University Of California, San Francisco · R01 · FY2025 · CA
AZD2171 and chemoradiation for newly diagnosed glioblastoma
$607,551Tracy T Batchelor · Massachusetts General Hospital · R01 · FY2011 · CA
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
$607,358Orly Alter · University Of Utah · U01 · FY2015 · CA
Precision magnetic hyperthermia by integrating magnetic particle imaging
$607,180Jeff W Bulte · Johns Hopkins University · R01 · FY2024 · CA
Imaging Guided Genomics of Malignant Transformation
$606,792Joseph F Costello · University Of California, San Francisco · R01 · FY2014 · CA
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$606,672David M. Ashley · Duke University · U19 · FY2021 · CA
Focused ultrasound pre-conditioning for augmented nanoparticle penetration in infiltrative gliomas
$606,239Richard J Price · University Of Virginia · R01 · FY2021 · EB